PARIS/NEW YORK (Reuters) - Alstom (ALSO.PA) said on Thursday it was not informed of any potential public tender offer for its shares, which opened 17 percent higher after Bloomberg reported that General Electric (GE.
NEW YORK (Reuters) - U.S. stocks dipped on Wednesday to snap a six-session winning streak as gains in Boeing and Gilead were offset by slides in AT&T and the wider biotech sector.
Takeover target Allergan Inc., the company that makes Botox, has adopted a "poison pill" defense intended to delay a buyout by Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman.
Apple's board just approved a big stock split and a boost to its share buyback plan. The stock will undergo a 7-to-1 split. And the share repurchase authorization has been increased to $90 billion from $60 billion.
Demand from homebuyers continues to outpace supply, according to new housing numbers released yesterday, and experts said relief from rising prices and low inventory isn't in sight anytime soon.